[Case report. Thrombolytic therapy 17 hours after acute myocardial infarct: assessing myocardial viability with 201 thallium imaging].
Lund
G K
GK
Abteilung für Kardiologie, Universitätskrankenhaus Hamburg-Eppendorf.
Koschyk
D H
DH
Nienaber
C A
CA
D015906:Angioplasty, Balloon, Coronary; D003131:Combined Modality Therapy; D017023:Coronary Angiography; D003326:Coronary Circulation / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects* / Q000502:physiology; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000628:therapy*; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging / Q000628:therapy; D011994:Recombinant Proteins / Q000008:administration & dosage; D013794:Thallium Radioisotopes; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D015899:Tomography, Emission-Computed, Single-Photon; D016277:Ventricular Function, Left / Q000502:physiology
D011994:Recombinant Proteins; D013794:Thallium Radioisotopes; D010959:Tissue Plasminogen Activator
Kasuistik. Thrombolysetherapie 17 Stunden nach akutem Myokardinfarkt: Nachweis von vitalem Myokard durch 201Thalliumaufnahme.